# Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol

> **NCT02170038** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 16 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Microgynon
- **DRUG:** Noristerat(BAY86-6308)

## Key facts

- **NCT ID:** NCT02170038
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-12
- **Final completion:** 2015-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02170038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02170038, "Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT02170038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*